Evidence brief · printable

Inflammatory Bowel Disease evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Inflammatory Bowel Disease

Print or save as PDF Fits on one A4 or Letter page.

Inflammatory Bowel Disease: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,303 matching trials) · https://research.opensourcemed.info/briefs/inflammatory-bowel-disease.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Vedolizumab 4 trials
  • Anti-TNF Therapy 2 trials
  • Mirikizumab 2 trials
  • AB (antibiotics) 1 trial
  • Adalimumab 1 trial
  • Adecatumumab (MT-201) 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Education, coaching and self-management 30 trials · 12 completed · 2 with results
  • Dietary patterns and specific diets 42 trials · 16 completed · 1 with results
  • Cognitive behavioural and related therapies 14 trials · 7 completed · 1 with results
  • Probiotics, prebiotics and synbiotics 16 trials · 6 completed · 1 with results
  • Nutrition counselling and food-based products 7 trials · 4 completed · 1 with results
  • Yoga, tai chi, qigong and pilates 2 trials · 2 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Vitamin D3
  • Curcumin
  • Resveratrol

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • ANCA Antibodies higher · Pang et al. 2020
  • ASCA Antibodies higher · Zholudev et al. 2004
  • CRP higher · Singh et al. 2023
  • ESR higher · Ondrejčáková et al. 2024
  • Fecal Calprotectin higher · Tibble et al. 2001

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease… NCT06581328
  • A Long-Term Extension Study of Vedolizumab in Children and Teenagers With… NCT06405087
  • A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric… NCT04844606
  • Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory… NCT07353853
  • Automated Clinical Pathway for Inflammatory Bowel Disease Care NCT07167836
  • Personalized B-fructan Diet in Inflammatory Bowel Disease Patients NCT05615779

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Supplements and nutraceuticals: inflammation and other biomarkers 27 trials, no results posted yet
  • Exercise and physical activity: inflammation and other biomarkers 11 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (249 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.